Details for Patent: 5,900,423
✉ Email this page to a colleague
Title: | Form of paroxetine hydrochloride anhydrate |
Abstract: | "Paroxetine hydrochloride (I) anhydrate ##STR1## free of bound propan-2-ol, and various forms thereof, are useful in the treatment of depression and other disorders for which administration of selective serotonin reuptake inhibitors are indicated." |
Inventor(s): | Ward; Neal (Crowborough, GB), Jacewicz; Victor Witold (Tunbridge Wells, GB) |
Assignee: | SmithKline Beecham Corporation (Philadelphia, PA) |
Filing Date: | Sep 02, 1997 |
Application Number: | 08/922,060 |
Claims: | 1. Paroxetine hydrochloride anhydrate in Form A, which form comprises the following characteristics: a melting point of about 123-125.degree. C.; IR bands at about 513, 538, 571, 592, 613, 665, 722, 761, 783, 806, 818, 839, 888, 906, 924, 947, 966, 982, 1006, 1034, 1068, 1091, 1134, 1194, 1221, 1248, 1286, 1340, 1387, 1493, 1513, 1562, 1604, 3402, and 3631 cm.sup.-1 ; maximum endotherm, measured at 10.degree. C. per minute, of about 126.degree. C. in an open pan and about 121.degree. C. in a closed pan; characteristic X-ray diffractogram peaks at about 6.6, 8.0, 11.2, and 13.1 degrees 2 theta; characteristic solid state .sup.13 C-NMR spectrum peaks at about 154.3, 149.3, 141.6, and 138.5 ppm. |